{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:59:50Z","timestamp":1790315990217,"version":"4.1.0"},"reference-count":165,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Melanoma progression and therapeutic resistance are increasingly recognized as emergent properties of the dynamic interactions between tumor cells and their surrounding tumor microenvironment (TME). A central feature of this adaptability is melanoma cell plasticity, through which tumor cells reversibly transition between distinct transcriptional and functional states in response to microenvironmental and therapeutic pressures. Recent advances in single-cell RNA sequencing and spatial transcriptomics have revealed that these interactions are spatially organized, with distinct cellular compositions and signaling programs forming specialized microenvironmental niches. However, the mechanisms that coordinate these spatially and functionally heterogeneous states remain incompletely integrated. In this review, we propose that soluble mediator networks, including cytokines, chemokines, growth factors, metabolites, extracellular vesicle-associated signals, and stress-related mediators, provide a functional layer that links the different compartments of the melanoma TME. We organize this network into interconnected immunoregulatory, vascular and lymphatic, mechanotransductive\/ECM, and metabolic\/redox axes, and examine how their reciprocal interactions influence melanoma cell identity, immune surveillance, vascular function, tissue architecture, and metabolic adaptation. Particular attention is given to the context-dependent activity of soluble mediators, whose effects vary according to their cellular source, spatial distribution, disease stage, and therapeutic pressure. We further discuss how these signals converge within localized microenvironmental niches to promote melanoma plasticity, immune escape, metastatic dissemination, and therapeutic resistance. Emerging mechanisms, including metabolic rewiring, lactate signaling, oxidative stress, and transmissible endoplasmic reticulum stress, illustrate how adaptive information can propagate between the different compartments. Overall, we propose that therapeutic resistance should not be viewed solely as the consequence of tumor-intrinsic alterations or isolated resistance pathways, but as an emergent property of a continuously rewired tumor ecosystem. This perspective suggests that effective therapeutic strategies may require disruption of the adaptive communication networks that sustain resistant tumor states, rather than targeting individual molecular pathways in isolation.<\/jats:p>","DOI":"10.3389\/fcell.2026.1905416","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:32:07Z","timestamp":1790314327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A bittersweet symphony: soluble mediator networks orchestrate melanoma plasticity and therapeutic adaptation"],"prefix":"10.3389","volume":"14","author":[{"given":"Carmine","family":"Lauretta","sequence":"first","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Sorrentino","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Sabbatino","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Tutino","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Sim\u00e3o de Souza","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d","place":["Naples, Italy"]},{"name":"Department of Pharmacology, Laboratory of Experimental Endocrinology, Escola Paulista de Medicina (EPM), Universidade Federal de S\u00e3o Paulo (UNIFESP)","place":["S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antimo","family":"Migliaccio","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Castoria","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Giovannelli","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Di Donato","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cell.2009.07.049","article-title":"Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin","volume":"139","author":"Adameyko","year":"2009","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/pcmr.12736","article-title":"Bad company: microenvironmentally mediated resistance to targeted therapy in melanoma","volume":"32","author":"Almeida","year":"2019","journal-title":"Pigment. Cell Melanoma Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jtcvs.2019.04.010","article-title":"Commentary: lobectomy or sublobar resection for early lung cancer: one small step for surgeons, one giant step for patients","volume":"158","author":"Altorki","year":"2019","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4946289","DOI":"10.1155\/2018\/4946289","article-title":"Targeting the endoplasmic reticulum unfolded protein response to counteract the oxidative stress-induced endothelial dysfunction","volume":"2018","author":"Amodio","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1158\/2767-9764.CRC-22-0090","article-title":"Mavorixafor, an orally bioavailable CXCR4 antagonist, increases immune cell infiltration and inflammatory status of tumor microenvironment in patients with melanoma","volume":"2","author":"Andtbacka","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","article-title":"Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment","volume":"43","author":"Apostolova","year":"2022","journal-title":"Trends Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1200\/jco.22.00221","article-title":"Phase II LEAP-004 study of lenvatinib plus pembrolizumab for melanoma with confirmed progression on a programmed cell death protein-1 or programmed death ligand 1 inhibitor given as monotherapy or in combination","volume":"41","author":"Arance","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.annonc.2025.08.008","article-title":"Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma","volume":"36","author":"Arance","year":"2025","journal-title":"Ann. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3389\/fonc.2020.00722","article-title":"Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment","volume":"10","author":"Avagliano","year":"2020","journal-title":"Front. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","article-title":"Nociceptor neurons affect cancer immunosurveillance","volume":"611","author":"Balood","year":"2022","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"20847","DOI":"10.1073\/pnas.0906481106","article-title":"Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity","volume":"106","author":"Balsamo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1111\/febs.15195","article-title":"Genome-wide mRNA profiling identifies RCAN1 and GADD45A as regulators of the transitional switch from survival to apoptosis during ER stress","volume":"287","author":"Bartoszewski","year":"2020","journal-title":"FEBS J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1755-148X.2009.00553.x","article-title":"Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin","volume":"22","author":"Bedogni","year":"2009","journal-title":"Pigment. Cell Melanoma Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1128\/MCB.00166-09","article-title":"Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains","volume":"29","author":"Bellot","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"873116","DOI":"10.3389\/fimmu.2022.873116","article-title":"Cancer cell phenotype plasticity as a driver of immune escape in melanoma","volume":"13","author":"Benboubker","year":"2022","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","article-title":"Brain metastasis","volume":"20","author":"Boire","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/1547691X.2012.723767","article-title":"Microenvironment and tumor progression of melanoma: new therapeutic prospectives","volume":"10","author":"Botti","year":"2013","journal-title":"J. Immunotoxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1158\/1078-0432.CCR-16-0460","article-title":"Role of the microenvironment in liver metastasis: from pre-to prometastatic niches","volume":"22","author":"Brodt","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/prot.22819","article-title":"Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase","volume":"78","author":"Capece","year":"2010","journal-title":"Proteins Struct. Funct. bioinform."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/cancers16101794","article-title":"Angiogenesis still plays a crucial role in human melanoma progression","volume":"16","author":"Cazzato","year":"2024","journal-title":"Cancers"},{"key":"B23","doi-asserted-by":"publisher","first-page":"970279","DOI":"10.3389\/fonc.2022.970279","article-title":"Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy","volume":"12","author":"Cerro","year":"2022","journal-title":"Front. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","article-title":"Amino acid metabolism in tumor biology and therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1754745","DOI":"10.3389\/fphys.2026.1754745","article-title":"Cutaneous lymphatics and skin diseases: mechanisms, imaging modalities, and future therapeutic strategies","volume":"17","author":"Chen","year":"2026","journal-title":"Front. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e982382","DOI":"10.4161\/2162402X.2014.982382","article-title":"Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma","volume":"4","author":"Chevolet","year":"2015","journal-title":"Oncoimmunology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/sji.12072","article-title":"Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications","volume":"78","author":"Chitadze","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40478-021-01273-9","article-title":"Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression","volume":"9","author":"Costa","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrc.2016.44","article-title":"Bone metastasis: the importance of the neighbourhood","volume":"16","author":"Croucher","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1098802","DOI":"10.1080\/2162402X.2015.1098802","article-title":"Targeting abnormal ER stress responses in tumors: a new approach to cancer immunotherapy","volume":"5","author":"Cubillos-Ruiz","year":"2015","journal-title":"Oncoimmunology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","article-title":"ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis","volume":"161","author":"Cubillos-Ruiz","year":"2015","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fcell.2018.00104","article-title":"Hypoxia and selective autophagy in cancer development and therapy","volume":"6","author":"Daskalaki","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.2979","article-title":"Tumor-macrophage interactions","volume":"15","author":"Dempsey","year":"2014","journal-title":"Nat. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41419-025-07350-4","article-title":"Role of the androgen receptor in melanoma aggressiveness","volume":"16","author":"Di Donato","year":"2025","journal-title":"Cell Death Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e63093","DOI":"10.7554\/eLife.63093","article-title":"MITF reprograms the extracellular matrix and focal adhesion in melanoma","volume":"10","author":"Dilshat","year":"2021","journal-title":"eLife"},{"key":"B39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41423-026-01411-0","article-title":"Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment","volume":"23","author":"Du","year":"2026","journal-title":"Cell Mol. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/cancers2020794","article-title":"Cytokines and growth factors expressed by human cutaneous melanoma","volume":"2","author":"Elias","year":"2010","journal-title":"Cancers (Basel)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00018-020-03517-8","article-title":"Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity","volume":"78","author":"\u00c9rsek","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.3390\/cancers12102870","article-title":"Tumor microenvironment: implications in melanoma resistance to targeted therapy and immunotherapy","volume":"12","author":"Falcone","year":"2020","journal-title":"Cancers"},{"key":"B43","doi-asserted-by":"publisher","first-page":"eaal4712","DOI":"10.1126\/scitranslmed.aal4712","article-title":"Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma","volume":"9","author":"Fankhauser","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumor environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.3390\/cancers15092607","article-title":"BRAF V600-Mutated metastatic melanoma and targeted therapy resistance: an update of the current knowledge","volume":"15","author":"Florent","year":"2023","journal-title":"Cancers"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/jbmr.3618","article-title":"Understanding the bone in cancer metastasis","volume":"33","author":"Fornetti","year":"2018","journal-title":"J. Bone Min. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejca.2020.12.021","article-title":"Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: an analysis of 112 cases","volume":"145","author":"Fujisawa","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s43018-021-00272-y","article-title":"Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-Dependent mechanism","volume":"2","author":"Garc\u00eda-Silva","year":"2021","journal-title":"Nat. Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1111\/jcmm.17794","article-title":"Targeting the YAP\/TAZ mechanotransducers in solid tumour therapeutics","volume":"27","author":"Gargalionis","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7064","DOI":"10.3390\/ijms26157064","article-title":"Roles of peripheral nerves in tumor initiation and progression","volume":"26","author":"Giampietri","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1007\/s00018-021-03873-z","article-title":"The pre-metastatic niche in lymph nodes: formation and characteristics","volume":"78","author":"Gillot","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1563303","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"116636","DOI":"10.1016\/j.intimp.2026.116636","article-title":"Perineural invasion: a neuroimmune axis mediating immunotherapy resistance across malignancies","volume":"179","author":"Guo","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12964-023-01438-0","article-title":"Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to immunotherapy","volume":"22","author":"He","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"B59","doi-asserted-by":"publisher","first-page":"43127","DOI":"10.18632\/oncotarget.5756","article-title":"Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma","volume":"6","author":"Hong","year":"2015","journal-title":"Oncotarget"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/ijms24021601","article-title":"Phenotype switching and the melanoma microenvironment; impact on immunotherapy and drug resistance","volume":"24","author":"Hossain","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"113068","DOI":"10.1016\/j.biopha.2022.113068","article-title":"Hypoxia, a key factor in the immune microenvironment","volume":"151","author":"Hu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","article-title":"Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy","volume":"18","author":"Hu","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1172\/JCI98060","article-title":"Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma","volume":"128","author":"Huber","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B64","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41568-025-00836-5","article-title":"Endoplasmic reticulum stress responses in anticancer immunity","volume":"25","author":"Hwang","year":"2025","journal-title":"Nat. Rev. Cancer."},{"key":"B65","doi-asserted-by":"publisher","first-page":"932055","DOI":"10.3389\/fimmu.2022.932055","article-title":"Lactate from the tumor microenvironment - a key obstacle in NK cell-based immunotherapies","volume":"13","author":"Jedli\u010dka","year":"2022","journal-title":"Front. Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3389\/fcell.2020.00846","article-title":"Transmissible endoplasmic reticulum stress: a novel perspective on tumor immunity","volume":"8","author":"Jiang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13046-022-02484-1","article-title":"The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?","volume":"41","author":"Jurj","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.2147\/OTT.S182721","article-title":"Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US food and Drug Administration-approved targeted therapy in advanced melanoma","volume":"11","author":"Kakadia","year":"2018","journal-title":"Onco Targets Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.3390\/cancers15123147","article-title":"Tumor microenvironment as a therapeutic target in melanoma treatment","volume":"15","author":"Kharouf","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fonc.2018.00067","article-title":"Impact of L-Arginine metabolism on immune response and anticancer immunotherapy","volume":"8","author":"Kim","year":"2018","journal-title":"Front. Oncol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"14403","DOI":"10.3390\/ijms241814403","article-title":"Exploring the complex and multifaceted interplay between melanoma cells and the tumor microenvironment","volume":"24","author":"Kuras","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1006\/cyto.1999.0614","article-title":"Autocrine and paracrine regulation by cytokines and growth factors in melanoma","volume":"12","author":"L\u00e1z\u00e1r-Moln\u00e1r","year":"2000","journal-title":"Cytokine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e12197","DOI":"10.1002\/jev2.12197","article-title":"Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes","volume":"11","author":"Leary","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"B80","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-030-40204-4_8","article-title":"The impact of the ER unfolded protein response on cancer initiation and progression: therapeutic implications","volume":"1243","author":"Lebeaupin","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/s41467-020-15726-7","article-title":"Transcriptional downregulation of MHC class I and melanoma de-differentiation in resistance to PD-1 inhibition","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1367875","DOI":"10.3389\/fimmu.2024.1367875","article-title":"Endothelial cells in tumor microenvironment: insights and perspectives","volume":"15","author":"Leone","year":"2024","journal-title":"Front. Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"8689","DOI":"10.3390\/ijms21228689","article-title":"The Angiopoietin-2 and TIE pathway as a therapeutic target for enhancing antiangiogenic therapy and immunotherapy in patients with advanced cancer","volume":"21","author":"Leong","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1038\/s41467-019-09525-y","article-title":"Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5\u2212\/\u2212 mice","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"B85","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"B86","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"633495","DOI":"10.3389\/fimmu.2021.663495","article-title":"Tumor immune microenvironment characterization identifies prognosis and immunotherapy-related gene signatures in melanoma","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e1392426","DOI":"10.1080\/2162402X.2017.1392426","article-title":"Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors","volume":"7","author":"L\u00f3pez-Cobo","year":"2018","journal-title":"Oncoimmunology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","article-title":"The extracellular matrix: a dynamic niche in cancer progression","volume":"196","author":"Lu","year":"2012","journal-title":"J. Cell. Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.celrep.2012.01.005","article-title":"VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics","volume":"1","author":"Lund","year":"2012","journal-title":"Cell Rep."},{"key":"B91","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell. Metab."},{"key":"B92","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1073\/pnas.1008942108","article-title":"Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells","volume":"108","author":"Mahadevan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B93","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer."},{"key":"B94","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e000764","DOI":"10.1136\/jitc-2020-000764","article-title":"Tumors establish resistance to immunotherapy by regulating treg recruitment via CCR4","volume":"8","author":"Marshall","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3390\/cells13221917","article-title":"Extracellular matrix as a target in melanoma therapy: from hypothesis to clinical trials","volume":"13","author":"Mayasin","year":"2024","journal-title":"Cells"},{"key":"B98","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/ijms22020529","article-title":"Stromal cells present in the melanoma niche affect tumor invasiveness and its resistance to therapy","volume":"22","author":"Mazurkiewicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/cells11071157","article-title":"Understanding molecular mechanisms of phenotype switching and crosstalk with TME to reveal new vulnerabilities of melanoma","volume":"11","author":"Najem","year":"2022","journal-title":"Cells"},{"key":"B101","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/jpm16020120","article-title":"Cytokine profiling in cutaneous melanoma: the emerging role of interleukins in prognostic stratification with an up-to-date overview of published data","volume":"16","author":"Negoveti\u0107","year":"2026","journal-title":"J. Pers. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1007\/s12672-025-03448-5","article-title":"Integrated pan-cancer and melanoma-specific analysis of angiopoietin-2: prognostic value, immune microenvironment modulation, and ceRNA network regulation","volume":"16","author":"Ni","year":"2025","journal-title":"Discov. Oncol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1158\/2159-8290.CD-21-1357","article-title":"The spatial landscape of progression and immunoediting in primary melanoma at single-cell resolution","volume":"12","author":"Nirmal","year":"2022","journal-title":"Cancer Discov."},{"key":"B104","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0304-419x(03)00004-0","article-title":"Autophagy: a barrier or an adaptive response to cancer","volume":"1603","author":"Ogier-Denis","year":"2003","journal-title":"Biochim. Biophys. Acta."},{"key":"B105","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1113\/JP270955","article-title":"Mitochondria and carbon monoxide: cytoprotection and control of cell metabolism - a role for Ca(2+)?","volume":"594","author":"Oliveira","year":"2016","journal-title":"J. Physiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/antiox12050981","article-title":"Unfolding the interactions between endoplasmic reticulum stress and oxidative stress","volume":"12","author":"Ong","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/cancers13051115","article-title":"Resistance to molecularly targeted therapies in melanoma","volume":"13","author":"Patel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B109","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"B110","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.3390\/cancers12113147","article-title":"Lipid metabolic reprogramming: Role in melanoma progression and therapeutic perspectives","volume":"12","author":"Pellerin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"key":"B113","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/ijms17060868","article-title":"Role of matrix metalloproteinases in photoaging and photocarcinogenesis","volume":"17","author":"Pittayapruek","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3390\/antiox10121942","article-title":"Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies","volume":"10","author":"Pizzimenti","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B115","doi-asserted-by":"publisher","first-page":"924553","DOI":"10.3389\/fonc.2022.924553","article-title":"Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance","volume":"12","author":"Popovic","year":"2022","journal-title":"Front. Oncol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3390\/cancers12102801","article-title":"Mechanisms of acquired BRAF inhibitor resistance in melanoma: a systematic review","volume":"12","author":"Proietti","year":"2020","journal-title":"Cancers"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1101\/gad.329771.119","article-title":"Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities","volume":"33","author":"Rambow","year":"2019","journal-title":"Genes Dev."},{"key":"B118","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.celrep.2014.06.059","article-title":"Role of Angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade","volume":"8","author":"Rigamonti","year":"2014","journal-title":"Cell Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1097\/j.pain.0000000000002169","article-title":"Demise of nociceptive schwann cells causes nerve retraction and pain hyperalgesia","volume":"162","author":"Rinwa","year":"2021","journal-title":"Pain"},{"key":"B121","doi-asserted-by":"publisher","first-page":"7419","DOI":"10.3390\/ijms26157419","article-title":"Cancer stem cells in melanoma: drivers of tumor plasticity and emerging therapeutic strategies","volume":"26","author":"Sab\u0103u","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"B123","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.20892\/j.issn.2095-3941.2025.0048","article-title":"Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance","volume":"22","author":"Serrat\u00ec","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1284629","DOI":"10.3389\/fimmu.2024.1284629","article-title":"Involvement of neuronal factors in tumor angiogenesis and the shaping of the cancer microenvironment","volume":"15","author":"Shalabi","year":"2024","journal-title":"Front. Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2147\/OTT.S493643","article-title":"Exploring TGF-\u03b2 signaling in cancer progression: prospects and therapeutic strategies","volume":"18","author":"Sheikh","year":"2025","journal-title":"Onco Targets Ther."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/sj.onc.1210114","article-title":"Chemokine-mediated migration of melanoma cells towards Lymphatics\u2014A mechanism contributing to metastasis","volume":"26","author":"Shields","year":"2007","journal-title":"Oncogene"},{"key":"B128","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbrc.2023.06.090","article-title":"Fatty acid oxidation supports melanoma cell migration through autophagy regulation","volume":"674","author":"Shin","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B129","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.3390\/ijms26146778","article-title":"Tumor microenvironment in Melanoma\u2014Characteristic and clinical implications","volume":"26","author":"Sikorski","year":"2025","journal-title":"Int. J. Mol.Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"8359","DOI":"10.3390\/ijms21218359","article-title":"The influence of tumor microenvironment on immune escape of melanoma","volume":"21","author":"Simiczyjew","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1016\/j.celrep.2018.11.047","article-title":"Magnitude of therapeutic STING activation determines CD8+ T cell-mediated anti-tumor immunity","volume":"25","author":"Sivick","year":"2018","journal-title":"Cell Rep."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1158\/2159-8290.CD-13-1007","article-title":"The immune-microenvironment confers resistance to MAP kinase pathway inhibitors through macrophage-derived TNF\u03b1","volume":"4","author":"Smith","year":"2014","journal-title":"Cancer Discov."},{"key":"B133","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2217\/mmt.15.37","article-title":"The role of tumor microenvironment in melanoma therapy resistance","volume":"3","author":"Somasundaram","year":"2016","journal-title":"Melanoma Manag."},{"key":"B134","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41419-026-08469-8","article-title":"Rewiring melanoma cell fate: TRPM8 modulators trigger apoptosis and boost NK cell cytotoxicity","volume":"17","author":"Sorrentino","year":"2026","journal-title":"Cell Death Dis."},{"key":"B135","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.jid.2023.10.047","article-title":"Skin innervation","volume":"144","author":"St\u00e4nder","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1158\/0008-5472.CAN-16-1755","article-title":"Myeloid cells that impair immunotherapy are restored in melanomas which acquire resistance to BRAF inhibitors","volume":"77","author":"Steinberg","year":"2017","journal-title":"Cancer Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2023.07.002","article-title":"Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis","volume":"44","author":"Suman","year":"2023","journal-title":"Trends Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41577-025-01221-x","article-title":"Regulators of CD8+ T cell exhaustion","volume":"26","author":"Sun","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"909580","DOI":"10.3389\/fimmu.2022.909580","article-title":"Metabolic rewiring directs melanoma immunology","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"218460","DOI":"10.1016\/j.canlet.2026.218460","article-title":"Cancer neuroscience: dissecting autonomic and sensory neural regulation of tumor progression and therapeutic resistance","volume":"648","author":"Sun","year":"2026","journal-title":"Cancer Lett."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e70090","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"B143","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/cancers8030030","article-title":"Melanoma and the unfolded protein response","volume":"8","author":"Sykes","year":"2016","journal-title":"Cancers (Basel)"},{"key":"B144","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.it.2022.10.010","article-title":"Lymph node lymphatic endothelial cells as multifaceted gatekeepers in the immune system","volume":"44","author":"Takeda","year":"2023","journal-title":"Trends Immunol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"eabm0631","DOI":"10.1126\/sciimmunol.abm0631","article-title":"Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function","volume":"7","author":"Tang","year":"2022","journal-title":"Sci. Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-Seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/ph18081082","article-title":"Tumor microenvironmental dynamics in shaping resistance to therapeuticinterventions in melanoma: a narrative review","volume":"18","author":"Turner","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B148","doi-asserted-by":"publisher","first-page":"EMMM202318028","DOI":"10.15252\/emmm.202318028","article-title":"Tumor endothelial cell autophagy is a key vascular\u2010immune checkpoint in melanoma","volume":"15","author":"Verhoeven","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"B150","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B151","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrc3800","article-title":"The impact of the endoplasmic reticulum protein-folding environment on cancer development","volume":"14","author":"Wang","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"B152","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-Dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"B153","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"key":"B154","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1038\/s41598-019-46594-x","article-title":"SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait","volume":"9","author":"Wu","year":"2019","journal-title":"Sci. Rep."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1028647","DOI":"10.3389\/fphar.2022.1028647","article-title":"The role of angiogenesis in melanoma: clinical treatments and future expectations","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cytogfr.2024.02.003","article-title":"Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy","volume":"76","author":"Xu","year":"2024","journal-title":"Cytokine and Growth Factor Rev"},{"key":"B157","doi-asserted-by":"publisher","first-page":"124416","DOI":"10.1016\/j.lfs.2026.124416","article-title":"Schwann cells as immunomodulators in the tumor immune microenvironment: mechanisms and therapeutic implications","volume":"396","author":"Yang","year":"2026","journal-title":"Life Sci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41590-023-01723-7","article-title":"Breaking NGF-TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection","volume":"25","author":"Yin","year":"2024","journal-title":"Nat. Immunol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat. Med."},{"key":"B160","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/metabo15040221","article-title":"Endoplasmic reticulum stress and its role in metabolic reprogramming of cancer","volume":"15","author":"Zarrella","year":"2025","journal-title":"Metabolites"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1158\/2159-8290.CD-17-1371","article-title":"Adipocyte-derived lipids mediate melanoma progression via FATP proteins","volume":"8","author":"Zhang","year":"2018","journal-title":"Cancer Discov."},{"key":"B162","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41419-024-07122-6","article-title":"Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment","volume":"15","author":"Zheng","year":"2024","journal-title":"Cell Death Dis."},{"key":"B163","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40364-025-00883-y","article-title":"Tumor-associated endothelial cells in tumor immune escape and immunotherapy: multifaceted roles and treatment approaches","volume":"14","author":"Zheng","year":"2025","journal-title":"Biomark. Res."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/antiox10081167","article-title":"Roles and therapeutic implications of endoplasmic reticulum stress and oxidative stress in cardiovascular diseases","volume":"10","author":"Zhou","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/hmg\/ddae056","article-title":"Melanoma-associated fibroblasts in tumor-promotion inflammation and antitumor immunity: novel mechanisms and potential immunotherapeutic strategies","volume":"33","author":"Zhou","year":"2024","journal-title":"Hum. Mol. Genet."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1905416\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:32:09Z","timestamp":1790314329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1905416\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":165,"alternative-id":["10.3389\/fcell.2026.1905416"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1905416","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1905416"}}